8Lun·

It's starting to get interesting...

$IBRX (-7,75 %) News today on the approval of Anktiva in the EU. Yesterday big investor congress in Riyadh 📈🚀🧨 I am curious to see what comes next.

attachment
11
6 Comentarios

Imagen de perfil
I'm now in too ✅ I see great potential here. Would hold for the longer term, don't see it (just) as a momentum trade.
•
4
•
Imagen de perfil
Sounds exciting! Apparently only Merck is the current competition.
But I don't know if you want to jump in after them...
•
2
•
Imagen de perfil
New GQ hype share ?
OK, all on board !!! 😅
•
2
•
Imagen de perfil
@Tigawutz runs and runs.... Currently +50% in 4 days for me. And I got in really late.
•
1
•
Imagen de perfil
@Creutzfeldt_Jakob there's more to come ... this week there will be more information, next week earnings
•
1
•
Imagen de perfil
@Tigawutz I already wrote it: I'm staying in, don't just see it as a trade.
•
1
•
Únase a la conversación